Drug Discovery Conference | Drug delivery Conference | Paris | France | 2024

Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Drug Discovery, Drug Discovery Conference, Drug Discovery Conferences, Drug Discovery Congress, Drug Discovery Conference, Drug Discovery Conference, Drug delivery, Biotechnology, Toxicology

Ron Neumann

Co-Chairperson ISOPT Clinical Ocular Drug Development Expert Specializing in Inflammatory Eye Diseases Israel

Drug Discovery, Drug Discovery Conference, Drug Discovery Conferences, Drug Discovery Congress, Drug Discovery Conference, Drug Discovery Conference, Drug delivery, Biotechnology, Toxicology

Matan Avivi

The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan Israel

Drug Discovery, Drug Discovery Conference, Drug Discovery Conferences, Drug Discovery Congress, Drug Discovery Conference, Drug Discovery Conference, Drug delivery, Biotechnology, Toxicology

Katarzyna (Kate) Smietana McKinsey & Com

McKinsey & Company Poland

Drug Discovery, Drug Discovery Conference, Drug Discovery Conferences, Drug Discovery Congress, Drug Discovery Conference, Drug Discovery Conference, Drug delivery, Biotechnology, Toxicology

Amira M. Ghoneim

Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, Future University in Egypt Egypt

Drug Discovery, Drug Discovery Conference, Drug Discovery Conferences, Drug Discovery Congress, Drug Discovery Conference, Drug Discovery Conference, Drug delivery, Biotechnology, Toxicology

Matthew N Bahr

Glaxo Smith Kline USA

Drug Discovery, Drug Discovery Conference, Drug Discovery Conferences, Drug Discovery Congress, Drug Discovery Conference, Drug Discovery Conference, Drug delivery, Biotechnology, Toxicology

Damon Smith

Altus Formulation Canada

Drug Discovery, Drug Discovery Conference, Drug Discovery Conferences, Drug Discovery Congress, Drug Discovery Conference, Drug Discovery Conference, Drug delivery, Biotechnology, Toxicology

Stefan Bughi

Los Amigos National Rehabilitation Center USA

Drug Discovery, Drug Discovery Conference, Drug Discovery Conferences, Drug Discovery Congress, Drug Discovery Conference, Drug Discovery Conference, Drug delivery, Biotechnology, Toxicology

Volkmar Weissig

World Mitochondria Society USA

Drug Delivery-2024

Welcome Message

We are delighted to announce the 41st International Conference on Drug Discovery and Drug Delivery System (Drug Delivery-2024), scheduled to be held on November 28-29, 2024, in the vibrant city of Paris, France. This prestigious conference will serve as a global platform for experts, researchers, and industry leaders to engage in an interdisciplinary dialogue on the latest innovations and breakthroughs in drug discovery and delivery systems.

Themed “Innovations in Drug Discovery and Delivery Systems,” Drug Delivery-2024 will spotlight cutting-edge technologies, emerging research, and novel therapeutic approaches that are revolutionizing the pharmaceutical landscape. From the identification of new drug targets to the development of advanced delivery mechanisms, the conference will cover a wide spectrum of topics critical to the future of healthcare.

Key highlights include:

  • Advances in precision medicine and personalized drug therapies
  • Nanotechnology and novel drug delivery platforms
  • Innovations in biopharmaceuticals and biologics
  • Artificial intelligence and machine learning in drug discovery
  • Overcoming challenges in drug formulation and stability
  • Regulatory and ethical considerations in drug development

Drug Delivery-2024 offers a unique opportunity to engage with thought leaders from academia, industry, and regulatory agencies. Attendees will benefit from expert-led sessions, interactive workshops, and collaborative networking, gaining insights into the future direction of Pharmaceutical research and practice.

Join us in Paris for this exciting event, where science meets innovation, and be part of the global effort to enhance drug discovery and delivery systems for the benefit of patients worldwide.

About Us

The 41st International Conference on Drug Discovery and Drug Delivery System (Drug Delivery-2024) will be held on November 28-29, 2024, in Paris, France. Focused on the theme "Innovations in Drug Discovery and Delivery Systems," this conference brings together leading researchers, scientists, and industry professionals to explore the latest advancements in drug discovery and novel delivery technologies. Attendees will engage in discussions on cutting-edge research, emerging therapeutic strategies, and the integration of advanced technologies in pharmaceutical science.

Attendees can look forward to engaging with a distinguished lineup of keynote speakers, renowned experts, and rising stars in the field, who will share their insights, expertise, and experiences. Through keynote addresses, plenary sessions, interactive workshops, and poster presentations, participants will have ample opportunities to explore cutting-edge research, exchange ideas, and collaborate on solutions to the most pressing challenges facing the industry.

Sessions & Tracks

Session 1: Novel Drug Delivery Technologies

The session on Novel Drug Delivery Technologies will explore cutting-edge advancements in the field of pharmaceutical sciences aimed at enhancing drug delivery mechanisms. With the growing complexity of therapeutic needs, particularly in cancer, chronic diseases, and infectious diseases, novel delivery technologies offer revolutionary ways to improve drug efficacy, reduce side effects, and target treatment more precisely.

Session 2: Biomaterials and Biodegradable Polymers in Drug Delivery

This session will delve into the critical role of biomaterials and biodegradable polymers in advancing drug delivery systems. As the demand for safer, more efficient, and sustainable drug delivery methods increases, biomaterials offer innovative solutions. Attendees will explore how these materials improve drug stability, enhance targeted delivery, and ensure controlled release, all while minimizing toxicity and environmental impact. The session will also discuss the potential of biodegradable polymers in creating eco-friendly, patient-specific delivery systems.

Session 3: Gene Therapy and RNA-based Therapeutics

This session will explore the groundbreaking advancements in gene therapy and RNA-based therapeutics, two of the most transformative fields in modern medicine. These technologies hold the potential to treat, and in some cases cure, genetic disorders, cancers, and chronic diseases by targeting the underlying causes at the molecular level. The session will focus on the mechanisms, applications, and challenges of gene therapy and RNA-based therapeutics, as well as their potential to revolutionize personalized medicine.

Session 4: Drug Repurposing and Drug Rediscovery

This session will focus on the emerging field of drug repurposing and rediscovery, a strategic approach that seeks to identify new therapeutic uses for existing drugs. Drug repurposing offers a faster, cost-effective alternative to traditional drug development, leveraging previously approved or shelved compounds to treat different diseases. The session will explore the scientific, clinical, and economic advantages of repurposing drugs, providing insights into how this approach is unlocking new potential treatments for conditions ranging from cancer and infectious diseases to rare genetic disorders.

Session 5: Nanotechnology Applications in Drug Delivery

This session will focus on the revolutionary role of nanotechnology in drug delivery systems, a rapidly advancing field that leverages nanoscale materials to enhance therapeutic efficacy, improve drug targeting, and minimize side effects. By harnessing the unique properties of nanoparticles, nanotechnology enables precise delivery of drugs to specific cells or tissues, optimizing treatment outcomes for conditions such as cancer, cardiovascular diseases, and neurological disorders. The session will provide an in-depth exploration of different nanotechnology-based drug delivery systems, current applications, and emerging trends.

Session 6: Biopharmaceutical Formulation Development

This session will delve into the critical process of biopharmaceutical formulation development, which plays a vital role in transforming biological molecules into safe, stable, and effective therapeutic products. As biologics, including monoclonal antibodies, vaccines, and gene therapies, dominate the pharmaceutical landscape, formulating these complex molecules presents unique challenges. The session will focus on the scientific, technical, and regulatory aspects of developing stable formulations that ensure the efficacy, safety, and shelf-life of biopharmaceutical products.

Session 7: Drug Delivery Strategies for Cancer Therapy

This session will focus on innovative drug delivery strategies designed specifically for cancer therapy, aiming to improve therapeutic efficacy, minimize toxicity, and overcome the challenges of delivering anticancer drugs. Given the complexity of cancer as a disease, traditional drug delivery approaches often fail to effectively target tumors while sparing healthy tissue. This session will explore the latest advances in targeted delivery systems, nanotechnology, and personalized medicine that offer new hope for more efficient and safer cancer treatments.

Session 8: Regenerative Medicine and Tissue Engineering

This session will explore the cutting-edge field of regenerative medicine and tissue engineering, focusing on the development of therapies aimed at repairing, replacing, or regenerating damaged tissues and organs. Regenerative medicine holds immense potential for treating conditions that currently have limited or no treatment options by leveraging cellular and molecular therapies, biomaterials, and advanced engineering techniques. The session will provide an in-depth look at the latest advancements in tissue engineering, stem cell therapy, and the translation of regenerative medicine into clinical applications.

Session 9: Drug Delivery Challenges in Neurological Disorders

This session will address the significant challenges associated with drug delivery for neurological disorders, including Alzheimer's, Parkinson's, epilepsy, multiple sclerosis, and brain tumors. The complexity of the brain and central nervous system (CNS), coupled with the presence of the blood-brain barrier (BBB), makes effective drug delivery particularly difficult. This session will explore advanced delivery strategies designed to overcome these obstacles, with a focus on improving drug bioavailability, targeting, and therapeutic outcomes for patients with neurological conditions.

Session 10: Innovations in Oral Drug Delivery Systems

This session will highlight the latest advancements and emerging technologies in oral drug delivery systems, which are pivotal for developing effective and patient-friendly therapeutic solutions. Oral drug delivery remains the most preferred route for drug administration due to its convenience and non-invasive nature. However, ensuring that drugs are effectively absorbed and deliver therapeutic levels requires innovative strategies to overcome barriers such as poor solubility, stability, and gastrointestinal (GI) degradation. This session will explore cutting-edge approaches designed to enhance the bioavailability and efficacy of oral medications.

Session 11: Advances in Vaccine Delivery

This session will focus on the latest advancements in vaccine delivery technologies, exploring innovative methods designed to improve the efficacy, safety, and accessibility of vaccines. Effective vaccine delivery is crucial for optimizing immunization outcomes, especially in the context of emerging infectious diseases and global health challenges. Attendees will learn about cutting-edge approaches that enhance vaccine stability, targeting, and patient compliance, as well as the impact of these innovations on public health.

Session 12: Emerging Technologies in Drug Discovery

This session will delve into the latest technological advancements transforming drug discovery, offering insights into innovative methods and tools that are accelerating the development of new therapeutics. The drug discovery process is evolving rapidly with the integration of cutting-edge technologies, which are enhancing our ability to identify novel drug targets, streamline compound screening, and optimize lead compounds. Attendees will gain a comprehensive understanding of these emerging technologies and their impact on the future of drug discovery.

Session 13: Regulatory Considerations in Drug Development

This session will provide a thorough examination of the regulatory landscape in drug development, focusing on the key considerations and requirements for bringing new therapeutics to market. Navigating regulatory pathways is crucial for ensuring that drugs are safe, effective, and compliant with global standards. This session will cover the various stages of drug development, from preclinical research through clinical trials and regulatory approval, offering insights into the strategies for successful regulatory submissions and compliance.

Session 14: Future Perspectives in Drug Discovery and Delivery

This session will explore the future of drug discovery and delivery, highlighting the emerging trends, technologies, and innovative approaches that are set to shape the landscape of pharmaceuticals. With rapid advancements in science and technology, the drug discovery and delivery fields are evolving to address unmet medical needs more effectively. This session will provide insights into the future directions of drug development, focusing on how these advancements will impact therapeutic strategies and patient care.

Why To Attend?

The 41st International Conference on Drug Discovery and Drug Delivery System (Drug Delivery-2024) offers a unique platform for professionals across the pharmaceutical and biomedical industries to gain cutting-edge knowledge and foster innovation. Here’s why attending this event is invaluable:

  1. Access to Pioneering Research
    Stay ahead in the field by gaining firsthand insights into groundbreaking developments in drug discovery, novel delivery systems, and personalized medicine from global thought leaders.

  2. Expert-Led Discussions
    Engage in high-level discussions with leading researchers and industry professionals on emerging trends, such as AI in drug design, nanotechnology in drug delivery, and biopharmaceutical innovations.

  3. Networking with Global Leaders
    Network with top-tier scientists, Pharmaceutical executives, and regulatory experts from around the world, fostering collaborations that can lead to future research and development partnerships.

  4. Interactive Workshops and Case Studies
    Participate in hands-on sessions and real-world case studies that provide practical solutions to challenges in drug formulation, delivery, and stability, enhancing your expertise.

  5. Stay Updated on Regulatory Trends
    Learn about the latest regulatory frameworks and ethical considerations in drug development, ensuring that your projects remain compliant with global standards.

  6. Showcase Innovations
    Present your research, products, and ideas to a global audience, gaining exposure and feedback from leaders in the field, and positioning yourself at the forefront of pharmaceutical advancements.

Attending Drug Delivery-2024 will provide you with the tools, knowledge, and connections to push the boundaries of drug discovery and delivery, contributing to the future of healthcare and therapeutic innovation.

Market Analysis

The pharmaceutical industry is experiencing unprecedented growth and innovation, driven by advances in drug discovery and drug delivery systems. As we approach the "41st International Conference on Drug Discovery and Drug Delivery System", scheduled for November 28-29, 2024, in Paris, France, it's essential to understand the market dynamics and trends shaping the industry.

  1. Global Pharmaceutical Market Growth: The global pharmaceutical market continues to expand, driven by an aging population, rising prevalence of chronic diseases, and increasing healthcare expenditure. According to industry reports, the market is projected to reach a value of over $1.5 trillion by 2024, with steady growth across all segments, including innovative therapies and generic drugs.

  2. Focus on Innovation: Innovation remains a key driver of growth in the pharmaceutical industry, with companies investing heavily in research and development to bring novel therapies to market. The conference will provide a platform for showcasing the latest innovations in drug discovery and drug delivery systems, including advancements in targeted therapies, precision medicine, and biopharmaceuticals.

  3. Rise of Personalized Medicine: Personalized medicine is gaining traction as a promising approach to healthcare, leveraging advances in genomics, biomarkers, and data analytics to tailor treatments to individual patients. The conference will explore the role of personalized medicine in drug discovery and delivery, highlighting opportunities to improve patient outcomes and optimize therapeutic efficacy.

  4. Advancements in Drug Delivery Technology: Drug delivery technology continues to evolve rapidly, with innovations such as nanoparticle-based drug carriers, implantable devices, and targeted delivery systems revolutionizing the way drugs are administered. Sessions at the conference will delve into the latest advancements in drug delivery technology, offering insights into their applications, benefits, and commercial potential.

  5. Regulatory Landscape: The regulatory landscape for pharmaceuticals is becoming increasingly complex, with stringent requirements for safety, efficacy, and quality assurance. Attendees will gain valuable insights into regulatory considerations in drug development, including preclinical testing, clinical trial design, and approval pathways, ensuring compliance with regulatory standards and enhancing the likelihood of successful drug commercialization.

In conclusion, the 41st International Conference on Drug Discovery and Drug Delivery System comes at a pivotal moment in the pharmaceutical industry, offering attendees a unique opportunity to stay abreast of market trends, explore innovative solutions, and forge strategic partnerships that drive growth and innovation in the global pharmaceutical market.

Who Can Attend

The 41st International Conference on Drug Discovery and Drug Delivery System (Drug Delivery-2024) is a premier event designed for a diverse range of professionals involved in the pharmaceutical, biotechnology, and healthcare sectors. This conference offers a valuable opportunity for those dedicated to advancing the science and technology of drug discovery and delivery systems.

Here’s who should attend:

  1. Pharmaceutical Scientists and Researchers
    Individuals conducting cutting-edge research in drug discovery, development, and delivery will find this conference essential for sharing their work, learning from peers, and staying updated on the latest scientific advancements.

  2. Biotechnology and Biomedical Engineers
    Experts involved in the creation of innovative drug delivery platforms, nanotechnology, and bioengineering solutions will benefit from engaging with industry leaders and exploring the integration of technology into drug delivery systems.

  3. Pharmacologists and Toxicologists
    Professionals focusing on the safety, efficacy, and metabolism of new drug candidates will have the chance to discuss recent developments in pharmacodynamics, pharmacokinetics, and drug interactions.

  4. Regulatory Affairs Specialists
    Representatives working in regulatory bodies, compliance, and quality assurance will gain insights into the latest global regulatory trends and ethical considerations for drug approval processes.

  5. Healthcare Professionals and Clinicians
    Physicians, nurses, and healthcare providers who are involved in patient care related to drug therapies will benefit from the latest updates in therapeutic strategies, personalized medicine, and patient-centric delivery methods.

  6. Pharmaceutical and Biotech Industry Leaders
    Executives, R&D directors, and decision-makers from pharmaceutical companies will find opportunities to explore business development strategies, investment opportunities, and partnerships that drive innovation in the drug discovery and delivery fields.

  7. Academic Professors and Educators
    Academics involved in teaching, training, and mentoring future professionals in pharmaceutical sciences will benefit from the wealth of information, which can enhance curricula and inspire new lines of research.

  8. Students and Early Career Professionals
    Aspiring researchers, PhD students, and postdoctoral fellows are encouraged to attend to learn from experts, present their work, and establish connections that will advance their careers in drug discovery and delivery science.

  9. Contract Research Organizations (CROs) and Clinical Trial Specialists
    Professionals in CROs, clinical trial coordination, and study management will find valuable sessions on drug development pathways, from preclinical research to post-market surveillance.

  10. Industry Suppliers and Technology Developers
    Companies that provide tools, technologies, and services related to drug discovery and delivery systems can showcase their products, network with potential clients, and explore collaboration opportunities.

Drug Delivery-2024 is an essential event for professionals across all facets of the pharmaceutical and biotech industries. Whether you are a researcher, clinician, industry leader, or student, this conference offers unparalleled opportunities to learn, collaborate, and contribute to the future of drug discovery and delivery.

Societies and Associations

To Collaborate Scientific Professionals around the World

Conference Date November 28-29, 2024

Speaker Opportunity

Supported By

American Journal of Advanced Drug Delivery American Journal of Drug Delivery and Therapeutics

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by